default author photo

Kang Chen

Guangxi Medical University - Department of Hepatobiliary Surgery

SCHOLARLY PAPERS

2

DOWNLOADS

142

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Adjuvant Immune Checkpoint Inhibitors Associated with Higher Recurrence-Free Survival in Postoperative Hepatocellular Carcinoma (PREVENT): A Prospective, Multicentric Cohort Study

Number of pages: 20 Posted: 03 Apr 2023
Le Li, Pei-Sheng Wu, Xiu-Mei Liang, Kang Chen, Guan-Lan Zhang, Qi-Bin Su, Rongrui Huo, Rong-Wei Xie, Shan Huang, Liang Ma and Jianhong Zhong
Guangxi Medical University - Department of Hepatobiliary Surgery, First People’s Hospital of Qinzhou - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, First People’s Hospital of Qinzhou - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery and Guangxi Medical University - Department of Hepatobiliary Surgery
Downloads 96 (720,278)

Abstract:

Loading...

Hepatocellular carcinoma, curative resection, adjuvant, high-risk, recurrence-free survival, immune checkpoint inhibitor

2.

Comparison of Post-Resection Survival between Patients with Hepatocellular Carcinoma Beyond the 'Up-To-7' Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: Prospective Data Analysis Based on Target Trial Emulation

Number of pages: 34 Posted: 25 Oct 2025
Jiayong Su, Tai-Xin Yang, guo pingping, Zhen Liu, Min Luo, Shao-Ping Liu, Xiao-Feng Dong, Xiao-Ling Xu, Shu-Chang Chen, Jun-Jie Ou, Kang Chen, Zhi-Cheng Li, Ze Su, Fu-Quan Yang, Wen-Hai He, Ning Peng, Pei-Sheng Wu, Bei-bei Long, Hang Su, Mei-Lan Huang, Wen-Ting Li, Wen-Ting Chen, Jian-Rong Li, Da-Long Yang, Zhi-Hao Huang, Lei-Po Lin, Rong-Rui Huo, Yi-Li Ma, Liang Ma, Xiao-Bin Zhong and Jianhong Zhong
Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Cancer Hospital, Liuzhou People's Hospital, Hospital of Nanning - The Second People's Hospital of Nanning, Guigang People's Hospital, People’s Hospital of Guangxi Zhuang Autonomous Region, People's Hospital of Wuzhou, Guangxi Medical University, Guangxi Medical University, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi University of Chinese Medicine (GXTCM), Nanning First People’s Hospital, Yulin First People's Hospital, Lingshan County People’s Hospital, Guangxi Medical University, First People’s Hospital of Qinzhou, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University, Guangxi Medical University, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery and Guangxi Medical University - Department of Hepatobiliary Surgery
Downloads 46 (1,133,231)

Abstract:

Loading...

Adjuvant, curative resection, hepatocellular carcinoma, PD-1 inhibitor, up-to-7 criterion